Woolsey, Courtney http://orcid.org/0000-0003-3389-0137
Jankeel, Allen
Matassov, Demetrius
Geisbert, Joan B.
Agans, Krystle N. http://orcid.org/0000-0002-7319-6935
Borisevich, Viktoriya
Cross, Robert W.
Deer, Daniel J.
Fenton, Karla A.
Latham, Theresa E.
Gerardi, Cheryl S.
Mire, Chad E. http://orcid.org/0000-0001-7596-1808
Eldridge, John H.
Messaoudi, Ilhem
Geisbert, Thomas W.
Article History
Received: 29 July 2019
Accepted: 28 January 2020
First Online: 20 February 2020
Competing interests
: The N2 rVSV vector described in this manuscript is the subject of a patent licensed to Profectus BioSciences. J.H.E. and T.W.G. claim intellectual property regarding recombinant VSV-based vaccines for the prevention and treatment of filovirus infections. All other authors report no potential conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.